Clinical Trial VICCBRE1271


Observational Pilot Study on MRI and Blood-Based Biomarkers of Chemotherapy-Related Cognitive Impairment

Principal Investigator(s)

Tricia Thornton-Wells


  • Protocol No. VICCBRE1271
  • Open Date: 01/09/2013
  • Staging: Pilot
  • Age Group: Adults
  • Scope: Local
  • Objective: Aim 1 - Evaluate the Relationship between Cognitive Impairment and MRI and Blood-Based Biomarkers Aim 2 - Identify Genetic Risk Factors for Chemotherapy-Induced Cognitive Impairment (CICI). Aim 3 - Develop and Compare Predictive Models for CICI using Genetic and MRI Biomarkers.
  • Disease Sites: Breast
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.